Skip to Content

Join the 'Wilms' Tumor' group to help and get support from people like you.

Wilms' Tumor News

Related terms: Cancer, Nephroblastoma, Cancer, Wilms' Tumor, Kidney Tumor

Childhood Cancer Survivors Now Living Healthier Lives

Posted 2 Jun 2017 by Drugs.com

FRIDAY, June 2, 2017 – For people who battled cancer in childhood, the prospects for a long life without cancer recurrence or chronic illness are better than ever, a new study finds. That's largely due to changes in cancer treatment protocols that have meant less toxicity to children and less chance for long-term side effects, researchers said. This is the first "comprehensive" study on the issue, said study author Dr. Todd Gibson, who's with the cancer control department at St. Jude Children's Research Hospital in Memphis, Tenn. As the researchers explained, more children are surviving cancer, but the chemotherapy and radiation they receive as treatment can raise their risk for adult illness years later. So, cancer specialists have worked hard over time to modify treatments to maximize benefits but minimize long-term risks. And it seems to have paid off. In the new study, Gibson's ... Read more

Related support groups: Cancer, Leukemia, Non-Hodgkin's Lymphoma, Acute Lymphoblastic Leukemia, Hodgkin's Lymphoma, Wilms' Tumor, History - Radiation Therapy

Another Study Ties Obesity to Certain Cancers

Posted 1 Mar 2017 by Drugs.com

WEDNESDAY, March 1, 2017 – Carrying extra weight increases the risk of a number of cancers, a new review reports. Additional pounds appear to particularly influence the risk of cancers related to the digestive organs or those driven by hormonal abnormalities, according to the review's European authors. The evidence is so strong at this point that important organizations such as the International Agency for Research on Cancer describe "excess body weight as an important cause of cancers," said Susan Gapstur. She's vice president of epidemiology at the American Cancer Society. The new evidence review was led by Maria Kyrgiou, of Imperial College London's Department of Surgery and Cancer. The review found that a jump in a person's body mass index (BMI) of 5 was associated with a higher cancer risk in the esophagus, bone marrow, biliary tract system, pancreas and kidneys. BMI is a rough ... Read more

Related support groups: Obesity, Cancer, Weight Loss, Breast Cancer, Prostate Cancer, Renal Cell Carcinoma, Colorectal Cancer, Ovarian Cancer, Pancreatic Cancer, Endometrial Cancer, Stomach Cancer, Wilms' Tumor, Gastric Cancer, Solid Tumors, Neoplasm of Bone, Insulinoma, Peritoneal Cancer, Giant Cell Tumor of Bone

Cancer Survivors Gain From Web-Based Health Care

Posted 10 Feb 2017 by Drugs.com

FRIDAY, Feb. 10, 2017 – Online- and phone-based health care offers a number of benefits for cancer survivors, British researchers report. The new study looked at previous research on cancer survivors' experiences with online and phone health contacts – what the researchers call telehealth. The review found that patients liked the flexibility and convenience of this method of staying in touch with their care providers because they could do so in a familiar, comfortable setting and with minimum disruption to their lives. The perceived anonymity of telehealth reduced patients' sense of vulnerability and some said they were more comfortable raising concerns in this setting than in face-to-face appointments. Negative aspects of telehealth mentioned by patients included not being able to meet their health care providers in person, while other patients said they couldn't use the service due ... Read more

Related support groups: Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Brain Tumor, Breast Cancer, Metastatic, Skin Cancer, Ovarian Cancer, Small Cell Lung Cancer, Bladder Cancer, Cervical Cancer, Breast Cancer, Prevention, Stomach Cancer, Head and Neck Cancer, Breast Cancer - Palliative, Testicular Cancer, Wilms' Tumor, Zollinger-Ellison Syndrome, Solid Tumors

Kidney Cancer Drug Shows Promise in Early Trial

Posted 30 Nov 2016 by Drugs.com

WEDNESDAY, Nov. 30, 2016 – An experimental drug may show promise in treating kidney cancer, researchers say. The drug CB-839 is the first to target an enzyme that cancer cells require to stay alive, researchers said. This stage 1 clinical trial found that the drug was effective in most patients with advanced kidney cancer when used in combination with another cancer drug called everolimus (Afinitor, Zortress). In the 15 patients in the study, the dual treatment controlled tumors in 93 percent of the patients, who had either clear cell or papillary renal cell cancer. Tumors shrank by more than 30 percent in one patient, were stable in 13 patients, and grew by more than 20 percent in one patient. Clear cell is the most common form of kidney cancer, accounting for 75 percent of cases, the researchers said. All 12 patients with this type of kidney cancer had their disease controlled. ... Read more

Related support groups: Renal Failure, Renal Cell Carcinoma, Chronic Kidney Disease, Afinitor, Peritoneal dialysis, Everolimus, Wilms' Tumor, Renal Osteodystrophy, Zortress, Hyperphosphatemia of Renal Failure, Afinitor Disperz

Do Overweight People Fare Better Than Others With Kidney Cancer?

Posted 7 Sep 2016 by Drugs.com

WEDNESDAY, Sept. 7, 2016 – Obesity is a risk factor for kidney cancer. Yet, obese people with advanced kidney cancer seem to live longer than normal-weight or underweight patients, a new study finds. In one database of nearly 2,000 patients with advanced kidney cancer, those who were obese or overweight survived nearly 26 months, compared to 17 months for those of normal weight. And, overweight patients were 16 percent less likely to die during the study period, the researchers reported. Similar findings were uncovered using three other databases. The records of more than 7,000 kidney cancer patients were reviewed by the study authors. "Paradoxically, when overweight individuals developed kidney cancer, especially in its advanced, metastatic form, their disease progressed more slowly and they lived longer than their normal-weight counterparts," said lead researcher Dr. Toni Choueiri. ... Read more

Related support groups: Obesity, Cancer, Renal Failure, Renal Cell Carcinoma, Chronic Kidney Disease, Wilms' Tumor, Urinary Tract Tumors, Urinary Tract Cancer

Some Advanced Kidney Cancer Patients May Postpone Treatment

Posted 4 Aug 2016 by Drugs.com

THURSDAY, Aug. 4, 2016 – Not all adults with advanced kidney cancer that has spread require immediate, aggressive treatment, a small new study suggests. "A subset of adults with advanced kidney cancer have slow-growing disease that can be safely managed using active surveillance," explained study lead author Brian Rini, of the Cleveland Clinic's Taussig Cancer Institute. This "watch and wait" approach, instead of active treatment, "could spare them the inconvenience and debilitating side effects of aggressive treatments for about a year, and in some cases several years, without worsening anxiety and depression," Rini said in a news release from The Lancet Oncology. The journal published the findings Aug. 4. In advanced kidney cancer, drugs such as sunitinib and sorafenib are typically used. While they can slow disease progression, they do not cure it, the researchers said. Could some ... Read more

Related support groups: Cancer, Renal Failure, Chronic Kidney Disease, Sutent, Nexavar, Sunitinib, Wilms' Tumor, Sorafenib, Urinary Tract Cancer

Could Talk Therapy Ease Chemo-Related Memory Issues?

Posted 2 May 2016 by Drugs.com

MONDAY, May 2, 2016 – A type of psychotherapy might help cancer survivors deal with the long-term thinking problems some experience after chemotherapy, researchers say. It's estimated that about half of those who undergo chemotherapy for cancer develop what's often called "chemo brain." For instance, they may have trouble following conversations or remembering the steps in a project, according to background notes with the new study. Although usually mild, these changes can affect quality of life, job performance and relationships, said the researchers from the Eastern Maine Medical Center and Lafayette Family Cancer Center in Bangor, Maine. The researchers developed a cognitive-behavioral therapy (CBT) program called Memory and Attention Adaptation Training to help cancer survivors prevent or manage these memory problems. Their study involved 47 breast cancer survivors who underwent ... Read more

Related support groups: Cancer, Methotrexate, Breast Cancer, Prostate Cancer, Fluorouracil, Lung Cancer, Gleevec, Renal Cell Carcinoma, Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic, Brain Tumor, Skin Cancer, Melanoma, Tasigna, Ovarian Cancer, Xeloda, Pancreatic Cancer, Nausea/Vomiting - Chemotherapy Induced, Endometrial Cancer

Certain Cancers Seem Less Likely for Kids of Hispanic Moms Born Outside U.S.

Posted 25 Apr 2016 by Drugs.com

MONDAY, April 25, 2016 – Children of Hispanic mothers who weren't born in the United States may be at lower risk for some types of childhood cancers, a new study suggests. "Incorporating the immigrant experience into studies of childhood cancer may help to inform research on disease [causes], identify vulnerable populations and highlight opportunities for cancer prevention," said Julia Heck, of the University of California, Los Angeles, and her study co-authors. It is important to evaluate childhood cancer risk in the large and growing Hispanic population, the research team said. For the study, the investigators analyzed data from children born in California between 1983 and 2012. The analysis was limited to children of U.S.-born white, U.S.-born Hispanic, or non-U.S.-born Hispanic mothers. Among the children, there were about 13,600 cancer diagnoses before age 6, and more than 15.5 ... Read more

Related support groups: Cancer, Acute Lymphoblastic Leukemia, Wilms' Tumor, Malignant Glioma, Neuroblastoma, Anaplastic Astrocytoma

Drug Seems to Extend Survival for Advanced Melanoma Patients

Posted 18 Apr 2016 by Drugs.com

MONDAY, April 18, 2016 – More than one-third of advanced melanoma patients were still alive five years after starting therapy with the cancer drug nivolumab (Opdivo), researchers are reporting. "In 2012, we saw some very promising early evidence that this drug could not only cause the regression of very advanced cancer in patients with melanoma, lung or kidney cancers that had not responded to other forms of therapy, but we also saw that these responses appeared to be very durable," said lead researcher Dr. Suzanne Topalian. She is a professor of surgery and oncology at Johns Hopkins University School of Medicine, in Baltimore. Opdivo was approved for the treatment of advanced melanoma by the U.S. Food and Drug Administration in 2014. The results of this follow-up study, funded by Bristol-Myers Squibb, which makes Opdivo, were to be presented Sunday at the American Association for ... Read more

Related support groups: Lung Cancer, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Melanoma, Small Cell Lung Cancer, Opdivo, Melanoma - Metastatic, Nivolumab, Wilms' Tumor

Is Type 1 Diabetes Linked to Raised Risk of Certain Cancers?

Posted 2 Mar 2016 by Drugs.com

TUESDAY, March 1, 2016 – Having type 1 diabetes may raise the risk of some cancers, but lower the risk of others, a new study suggests. A higher risk was seen for cancers of the stomach, liver, pancreas, endometrium, ovary and kidneys. But a reduced risk was seen for prostate and breast cancers, researchers reported. In type 1 diabetes, the body cannot produce the hormone insulin, which helps regulate blood sugar levels. People with type 1 diabetes must be treated with insulin to survive. The good news from this study, said researcher Sarah Wild, is that it doesn't seem that insulin treatment is responsible for an increased risk of some cancers, which has been a concern. "This pattern of cancer risk [seen in the study] is similar to that seen for people with type 2 diabetes and people who are overweight," said Wild, a professor of epidemiology at the University of Edinburgh in the ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Diabetes, Type 1, Renal Cell Carcinoma, Ovarian Cancer, Pancreatic Cancer, Diabetes Mellitus, Stomach Cancer, Wilms' Tumor

Fewer Childhood Cancer Survivors Dying From 'Late' Effects

Posted 13 Jan 2016 by Drugs.com

WEDNESDAY, Jan. 13, 2016 – Fewer childhood cancer survivors are dying years later from lingering effects of the treatment that conquered their cancer, a new study finds. Experts called the report, published in the Jan. 14 issue of the New England Journal of Medicine, "very good news." "The findings substantiate what experts in the field have hoped would be true," said lead researcher Dr. Gregory Armstrong, of St. Jude Children's Research Hospital, in Memphis, Tenn. Survival rates from many childhood cancers are high, but survivors still face what doctors call "late effects" – health problems that develop months to years after the cancer treatment has ended. Among U.S. children who survived cancer back in the 1970s and '80s, 18 percent died within the next 25 years, Armstrong said. Sometimes, the initial cancer comes back. Often though, the health issues are related to the very ... Read more

Related support groups: Cancer, Methotrexate, Fluorouracil, Xeloda, Hydroxyurea, Mercaptopurine, Hydrea, Cisplatin, Carboplatin, Cytoxan, Acute Lymphoblastic Leukemia, Bendamustine, Capecitabine, Cyclophosphamide, Temodar, Oxaliplatin, Hodgkin's Lymphoma, Gemzar, Dacogen, Gemcitabine

New Immune-Focused Drug Shows Promise Against Advanced Kidney Cancer

Posted 25 Sep 2015 by Drugs.com

FRIDAY, Sept. 25, 2015 – A new drug that harnesses the power of the immune system to fight tumors appears to help people battling advanced kidney cancer, a new study finds. The drug, Opdivo (nivolumab), outperformed a standard chemotherapy, Afinitor (everolimus), in terms of shrinking tumors and boosting patient survival, the study found. The study was funded by Bristol-Myers Squibb, which makes Opdivo. It was to be presented Friday at the European Cancer Congress in Vienna, and is being published simultaneously in the New England Journal of Medicine. The new findings "are significant and clinically meaningful to patients and health care professionals alike," senior researcher Dr. Padmanee Sharma, of the University of Texas M.D. Anderson Cancer Center in Houston, said in a meeting news release. Sharma, a professor in the departments of genitourinary medical oncology and immunology, ... Read more

Related support groups: Renal Cell Carcinoma, Afinitor, Opdivo, Wilms' Tumor

U.S. Oncologists Decry High Cost of Cancer Drugs

Posted 23 Jul 2015 by Drugs.com

THURSDAY, July 23, 2015 – Soaring costs for cancer drugs are hurting patient care in the United States, a group of top oncologists claim. "High cancer-drug prices are affecting the care of patients with cancer and our health care system," Dr. Ayalew Tefferi, a hematologist at Mayo Clinic in Rochester, Minn., said in a Mayo news release. Tefferi and his colleagues made a number of recommendations on how to address the problem in a commentary published July 23 in the Mayo Clinic Proceedings. Allowing Medicare to negotiate drug prices is one of the suggestions the team of 118 leading cancer experts offered as a possible solution. Along with their recommendations, the group also expressed support for a patient-based grassroots movement on change.org that is demanding action on the issue. "The average gross household income in the U.S. is about $52,000 per year. For an insured patient with ... Read more

Related support groups: Cancer, Provera, Depo-Provera, Methotrexate, Breast Cancer, Accutane, Lupron, Prostate Cancer, Medroxyprogesterone, Tamoxifen, Arimidex, Tretinoin, Lupron Depot, Fluorouracil, Femara, Lung Cancer, Gleevec, Rituxan, Renal Cell Carcinoma, Isotretinoin

Cancer Patients Should Ask Doctors to Use Simple Terms

Posted 28 Sep 2011 by Drugs.com

WEDNESDAY, Sept. 28 – Cancer patients are often faced with many difficult-to-understand treatment choices that can have serious side effects and even mean the difference between life and death. That's why it's crucial that patients insist doctors use plain language in explaining the options, advised Angela Fagerlin, an associate professor of internal medicine at the University of Michigan Medical School and a researcher at the U-M Comprehensive Cancer Center. "People are making life and death decisions that may affect their survival and they need to know what they're getting themselves into. Cancer treatments and tests can be serious. Patients need to know what kind of side effects they might experience as a result of the treatment they undergo," Fagerlin said in a university news release. She and her colleagues outlined a number of tips to help patients get the information they need ... Read more

Related support groups: Cancer, Provera, Depo-Provera, Methotrexate, Breast Cancer, Accutane, Lupron, Prostate Cancer, Medroxyprogesterone, Tamoxifen, Arimidex, Tretinoin, Lupron Depot, Fluorouracil, Femara, Lung Cancer, Gleevec, Rituxan, Renal Cell Carcinoma, Isotretinoin

Fewer Cancer Patients May Be Depressed Than Thought

Posted 20 Jan 2011 by Drugs.com

THURSDAY, Jan. 20 – The rate of depression among cancer patients may be lower than previously believed, a new study indicates. An international team of researchers analyzed 94 studies involving more than 14,000 patients and found that about one-sixth of cancer patients suffer depression and about one-third have a more widely defined mood disorder. Only modest rates of depression and anxiety occurred in cancer patients in the first five years after diagnosis, which suggests that depression is not inevitable in these patients, the researchers said. Only when it was combined with other mood disorders was depression common, occurring in 30 percent of hospitalized cancer patients. The study is published online Jan. 19 in The Lancet Oncology. Rates of depression and anxiety were not significantly different between patients receiving palliative care (care designed to ease pain and increase ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Renal Cell Carcinoma, Basal Cell Carcinoma, Colorectal Cancer, Non-Small Cell Lung Cancer, Brain Tumor, Breast Cancer, Metastatic, Skin Cancer, Osteosarcoma, Melanoma, Ovarian Cancer, Pancreatic Cancer, Endometrial Cancer, Small Cell Lung Cancer, Breast Cancer - Adjuvant, Bladder Cancer, Cervical Cancer

Page 1 2 Next

Ask a Question

Further Information

Related Condition Support Groups

Renal Cell Carcinoma

Related Drug Support Groups

Taxol, cyclophosphamide, paclitaxel, doxorubicin, vincristine, Adriamycin, Oncovin, dactinomycin, Cosmegen, Onxol, Vincasar PFS, Adriamycin RDF, Adriamycin PFS